De
Definiens
Munich DEFounded 2002100 employees
Private CapbiotechPrivateOncology
Platform: AI Tissue Pathology
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| DEF-8311 | DEF-8311 | Phase 1/2 | 2 | KRASG12C | Urothelial CaCeliac | ||
| Gozefutibatinib | DEF-5836 | Preclinical | 2 | TIM-3 | EoE |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (4)